Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Identifying the cheapest index funds for IRAs involves weighing costs against expected returns and risk. Learn practical benchmarking steps here.
22,746 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Bank of America named two new leaders to oversee digital assets and AI transformation, signaling a strategic push to ...
Britain is poised to appoint its next prime minister, but the bond market is already setting the terms. Investors mov...
A timing mishap reveals more than a celebrity scoop—it shows how quick news can ripple through budgets and plans. Thi...
A leading home-health provider delivered a 74% rise over 12 months, while a prominent fund expanded its ownership to ...
Bitcoin faces renewed pressure as a large overnight repo operation from the Federal Reserve coincides with stress in ...
A U.S. freeskier who once faced a public jab from the president miles ahead in the Olympic season posts a strong qual...
A sharp stock drop often triggers fear, but a sizable buy can signal belief in a company’s growth path. This article ...
Coinbase teams up with Yahoo Finance to let all U.S. users trade crypto directly from Yahoo asset pages. The move bro...
The latest price action has Diageo investors jittery as diageo stock sinking further raises questions about dividend ...
Carl Icahn’s latest stake move in Icahn Enterprises drew attention from investors. This article breaks down what icah...
A fresh stake from Cross Staff Investments in the Akre Focus ETF could signal a manager’s confidence in Akre’s approa...